Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care.

anticoagulation therapy cancer-associated thrombosis chemotherapy neoadjuvant treatment pancreatic ductal adenocarcinoma venous thromboembolism

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
08 Jul 2023
Historique:
received: 17 05 2023
revised: 27 06 2023
accepted: 06 07 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Recent studies have shown that patients with pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant chemo(radio)therapy followed by surgery have an improved outcome compared to patients treated with upfront surgery. Hence, patients with PDAC are more and more frequently treated with chemotherapy in the neoadjuvant setting. PDAC patients are at a high risk of developing venous thromboembolism (VTE), which is associated with decreased survival rates. As patients with PDAC were historically offered immediate surgical resection, data on VTE incidence and associated preoperative risk factors are scarce. Current guidelines recommend primary prophylactic anticoagulation in selected groups of patients with advanced PDAC. However, recommendations for patients with (borderline) resectable PDAC treated with chemotherapy in the neoadjuvant setting are lacking. Nevertheless, the prevention of complications is crucial to maintain the best possible condition for surgery. This narrative review summarizes current literature on VTE incidence, associated risk factors, risk assessment tools, and primary thromboprophylaxis in PDAC patients treated with neoadjuvant chemo(radio)therapy.

Identifiants

pubmed: 37509209
pii: cancers15143546
doi: 10.3390/cancers15143546
pmc: PMC10376958
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Thromb Haemost. 2006 Nov;4(11):2384-90
pubmed: 16881934
J Clin Invest. 1989 Feb;83(2):688-97
pubmed: 2913056
Surg Today. 2014 Sep;44(9):1660-8
pubmed: 24687760
JAMA Surg. 2016 Aug 17;151(8):e161137
pubmed: 27275632
J Thromb Haemost. 2012 Jul;10(7):1363-70
pubmed: 22520016
J Cancer Res Ther. 2020;16(7):1672-1677
pubmed: 33565515
Lancet Oncol. 2009 Oct;10(10):943-9
pubmed: 19726226
Best Pract Res Clin Haematol. 2009 Mar;22(1):9-23
pubmed: 19285269
Gut. 2019 Jan;68(1):130-139
pubmed: 29158237
Oncologist. 2020 Dec;25(12):1075-1083
pubmed: 32969580
Pancreas. 2017 Sep;46(8):1069-1075
pubmed: 28787333
J Clin Oncol. 2022 Apr 10;40(11):1220-1230
pubmed: 35084987
N Engl J Med. 1997 Sep 4;337(10):688-98
pubmed: 9278467
Blood. 2008 May 15;111(10):4902-7
pubmed: 18216292
Ann Oncol. 2007 Oct;18(10):1660-5
pubmed: 17660490
JAMA Oncol. 2021 Mar 1;7(3):421-427
pubmed: 33475684
Oncotarget. 2018 May 29;9(41):26453-26465
pubmed: 29899870
HPB (Oxford). 2021 Jan;23(1):80-89
pubmed: 32444267
Eur J Surg Oncol. 2021 Mar;47(3 Pt B):699-707
pubmed: 33280952
J Natl Compr Canc Netw. 2021 Oct 15;19(10):1181-1201
pubmed: 34666313
Thromb Res. 2018 Apr;164 Suppl 1:S112-S118
pubmed: 29703467
PLoS One. 2013 Sep 04;8(9):e73447
pubmed: 24023876
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Clin Res Hepatol Gastroenterol. 2013 Jun;37(3):230-9
pubmed: 23415988
J Cancer Res Clin Oncol. 2021 Nov;147(11):3447-3454
pubmed: 33715087
JAMA Oncol. 2022 Sep 1;8(9):1263-1270
pubmed: 35834226
Eur J Intern Med. 2022 Nov;105:30-37
pubmed: 35931614
J Thromb Haemost. 2007 Mar;5(3):632-4
pubmed: 17319909
J Thromb Haemost. 2008 Nov;6(11):1983-5
pubmed: 18795992
Br J Clin Pharmacol. 2013 Sep;76(3):338-47
pubmed: 23834355
Hematology Am Soc Hematol Educ Program. 2013;2013:684-91
pubmed: 24319253
Europace. 2021 Oct 9;23(10):1612-1676
pubmed: 33895845
J Clin Oncol. 2020 Feb 10;38(5):496-520
pubmed: 31381464
J Clin Oncol. 2009 Oct 10;27(29):4839-47
pubmed: 19720906
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Blood Adv. 2022 May 24;6(10):2967-2976
pubmed: 35045569
J Clin Oncol. 2015 Jun 20;33(18):2028-34
pubmed: 25987694
N Engl J Med. 2019 Feb 21;380(8):711-719
pubmed: 30511879
HPB (Oxford). 2015 Sep;17(9):824-31
pubmed: 26223388
N Engl J Med. 2019 Feb 21;380(8):720-728
pubmed: 30786186
Ann Surg Oncol. 2016 Dec;23(13):4352-4360
pubmed: 27370653
Blood. 2021 Apr 8;137(14):1959-1969
pubmed: 33171494
Blood. 2008 Oct 1;112(7):2703-8
pubmed: 18539899
Curr Drug Targets. 2007 Sep;8(9):966-1002
pubmed: 17896948
J Gen Intern Med. 2006 Jul;21(7):722-7
pubmed: 16808773
N Engl J Med. 2012 Feb 16;366(7):601-9
pubmed: 22335737
N Engl J Med. 2002 Mar 28;346(13):975-80
pubmed: 11919306
Cancer Med. 2020 Sep;9(17):6196-6204
pubmed: 32663379
Rejuvenation Res. 2013 Jun;16(3):224-31
pubmed: 23521603
J Clin Oncol. 2023 Jun 1;41(16):2926-2938
pubmed: 36626707
Pancreatology. 2017 May - Jun;17(3):464-470
pubmed: 28366422
J Clin Oncol. 2011 May 20;29(15):2099-103
pubmed: 21464402
Thromb Res. 2017 Feb;150:30-32
pubmed: 28002757
Haematologica. 2019 Jun;104(6):1277-1287
pubmed: 30606788
Arch Intern Med. 2004 Jan 26;164(2):190-4
pubmed: 14744843
Arch Intern Med. 2000 Mar 27;160(6):809-15
pubmed: 10737280
Cancer. 2007 Nov 15;110(10):2339-46
pubmed: 17918266
Ann Surg Oncol. 2019 May;26(5):1503-1511
pubmed: 30652227
Thromb Res. 2018 Jun;166:54-59
pubmed: 29656167
Arch Intern Med. 2006 Feb 27;166(4):458-64
pubmed: 16505267
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
PLoS Med. 2010 Apr 20;7(4):e1000267
pubmed: 20422030
Thromb Haemost. 2017 Sep 21;117(11):2135-2145
pubmed: 28933799
United European Gastroenterol J. 2020 Nov;8(9):1106-1114
pubmed: 32615874
Eur J Cancer. 2012 Jun;48(9):1283-92
pubmed: 22100906
Thromb Res. 2021 Jun;202:151-154
pubmed: 33857789
HPB (Oxford). 2022 May;24(5):575-585
pubmed: 35063354
Cancer. 2013 Feb 1;119(3):648-55
pubmed: 22893596
J Am Coll Surg. 2019 Feb;228(2):161-170.e2
pubmed: 30414453
Ann Oncol. 2023 May;34(5):452-467
pubmed: 36638869
Br J Clin Pharmacol. 2013 Sep;76(3):455-66
pubmed: 23305158
Gastroenterology. 2020 Apr;158(5):1346-1358.e4
pubmed: 31843588
Hematol Oncol Stem Cell Ther. 2010;3(4):191-5
pubmed: 21150239
Ann Surg. 2020 Sep 1;272(3):481-486
pubmed: 32740235
J Thromb Haemost. 2020 Aug;18(8):1940-1951
pubmed: 32336010
Thromb Res. 2016 Dec;148:63-69
pubmed: 27815968
Eur J Cancer. 2006 Feb;42(3):410-4
pubmed: 16321518
J Gastrointest Surg. 2022 Oct;26(10):2148-2157
pubmed: 35819666
Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2605-10
pubmed: 20729288
Surgery. 2007 Jul;142(1):20-5
pubmed: 17629996
J Surg Oncol. 2023 Mar;127(3):413-425
pubmed: 36367398
J Pharmacol Exp Ther. 2011 Jul;338(1):372-80
pubmed: 21515813
Pancreatology. 2017 Jul - Aug;17(4):629-634
pubmed: 28462862
Lancet Haematol. 2020 Oct;7(10):e746-e755
pubmed: 32976752
Hemasphere. 2022 Jul 13;6(8):e750
pubmed: 35924068
Thromb Res. 2013 Aug;132(2):180-4
pubmed: 23856554
BMC Cancer. 2021 Mar 23;21(1):300
pubmed: 33757440
Br J Surg. 2018 Jul;105(8):946-958
pubmed: 29708592
Arch Intern Med. 1964 Oct;114:497-500
pubmed: 14184638
Blood. 2017 Sep 28;130(13):1499-1506
pubmed: 28807983
Mol Clin Oncol. 2015 Jul;3(4):902-908
pubmed: 26171204
Ann Surg. 2006 Jan;243(1):89-95
pubmed: 16371741
Cancer Chemother Pharmacol. 2019 Jan;83(1):27-42
pubmed: 30446786
J Thromb Haemost. 2020 Nov;18(11):2852-2860
pubmed: 32767653
Cancers (Basel). 2020 Sep 03;12(9):
pubmed: 32899157
J Clin Oncol. 2023 Jun 1;41(16):2911-2925
pubmed: 36730884
Thromb Res. 2021 Aug 8;207:134-139
pubmed: 34628229
Lancet Oncol. 2022 Jul;23(7):e334-e347
pubmed: 35772465
J Clin Oncol. 2006 Jan 20;24(3):484-90
pubmed: 16421425
Cancers (Basel). 2018 Oct 11;10(10):
pubmed: 30314362
Lancet Oncol. 2016 Jun;17(6):801-810
pubmed: 27160474
Br J Cancer. 2016 Jul 26;115(3):332-8
pubmed: 27404454
J Thromb Haemost. 2010 Jan;8(1):114-20
pubmed: 19889150
Cancer. 2005 Dec 15;104(12):2822-9
pubmed: 16284987
BMC Cancer. 2018 Dec 17;18(1):1260
pubmed: 30558603
Lancet Haematol. 2018 Jul;5(7):e289-e298
pubmed: 29885940
Clin Transl Oncol. 2014 Oct;16(10):927-30
pubmed: 24643701
J Clin Oncol. 2012 Dec 10;30(35):4416-26
pubmed: 23150697
Oncologist. 2017 May;22(5):601-608
pubmed: 28424324
Thromb Res. 2017 Sep;157:9-15
pubmed: 28675831
Cancer. 2012 Jun 15;118(12):3053-61
pubmed: 21989534
Oncologist. 2020 Feb;25(2):e284-e290
pubmed: 32043787
PLoS Med. 2012;9(7):e1001275
pubmed: 22859911
Clin Cancer Res. 2007 May 15;13(10):2870-5
pubmed: 17504985
J Thromb Haemost. 2020 Jun;18(6):1291-1301
pubmed: 32108990
Cancers (Basel). 2020 Jul 24;12(8):
pubmed: 32722064
J Surg Oncol. 2016 Oct;114(5):581-586
pubmed: 27760280
Lancet Gastroenterol Hepatol. 2023 Feb;8(2):157-168
pubmed: 36521500
J Clin Oncol. 2009 Sep 1;27(25):4124-9
pubmed: 19636003
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):285-294
pubmed: 31953079
Blood Coagul Fibrinolysis. 2009 Apr;20(3):170-5
pubmed: 19276795
J Am Heart Assoc. 2020 Jul 7;9(13):e017559
pubmed: 32538234
N Engl J Med. 2013 Oct 31;369(18):1691-703
pubmed: 24131140
Cancer Chemother Pharmacol. 2018 Aug;82(2):245-250
pubmed: 29846765
Thromb Haemost. 2011 Aug;106(2):371-8
pubmed: 21713322
Br J Surg. 2019 May;106(6):765-773
pubmed: 30776085
Am J Hematol. 2019 Jul;94(7):780-785
pubmed: 31006890

Auteurs

R A L Willems (RAL)

Department of Functional Coagulation, Synapse Research Institute, 6217 KD Maastricht, The Netherlands.
Thrombosis Expert Center Maastricht, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands.
Department of Internal Medicine, Section Vascular Medicine, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands.
Department of Internal Medicine, Section Medical Oncology, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands.
CARIM, School for Cardiovascular Diseases, 6229 ER Maastricht, The Netherlands.

N Michiels (N)

Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

V R Lanting (VR)

Department of Internal Medicine, Section Vascular Medicine, University of Amsterdam, Amsterdam UMC Location, 1105 AZ Amsterdam, The Netherlands.
Amsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, 1081 HV Amsterdam, The Netherlands.
Tergooi Hospitals, Internal Medicine, 1201 DA Hilversum, The Netherlands.

S Bouwense (S)

Department of Surgery, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands.
NUTRIM, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.

B L J van den Broek (BLJ)

Department of Surgery, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands.

M Graus (M)

Department of Internal Medicine, Section Medical Oncology, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands.
GROW, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.

F A Klok (FA)

Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

B Groot Koerkamp (B)

Department of Surgery, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands.

B de Laat (B)

Department of Functional Coagulation, Synapse Research Institute, 6217 KD Maastricht, The Netherlands.
CARIM, School for Cardiovascular Diseases, 6229 ER Maastricht, The Netherlands.
Department of Platelet Pathophysiology, Synapse Research Institute, 6217 KD Maastricht, The Netherlands.

M Roest (M)

Department of Platelet Pathophysiology, Synapse Research Institute, 6217 KD Maastricht, The Netherlands.

J W Wilmink (JW)

Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.
Department of Medical Oncology, Amsterdam University Medical Center, Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

N van Es (N)

Department of Internal Medicine, Section Vascular Medicine, University of Amsterdam, Amsterdam UMC Location, 1105 AZ Amsterdam, The Netherlands.
Amsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, 1081 HV Amsterdam, The Netherlands.

J S D Mieog (JSD)

Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

H Ten Cate (H)

Thrombosis Expert Center Maastricht, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands.
Department of Internal Medicine, Section Vascular Medicine, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands.
CARIM, School for Cardiovascular Diseases, 6229 ER Maastricht, The Netherlands.

J de Vos-Geelen (J)

Department of Internal Medicine, Section Medical Oncology, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands.
GROW, Maastricht University Medical Center, 6229 ER Maastricht, The Netherlands.

Classifications MeSH